Lonn, L., Stroomberg, H. V., Brasso, K., Roder, M. A., Svarc, P., Jensen, R. J., . . . Taudorf, M. (2021). Efficacy of dexamethasone in reducing the postembolisation syndrome in men undergoing prostatic artery embolisation for benign prostatic hyperplasia: Protocol for a single-centre, randomised, double-blind, placebo-controlled trial—the ‘DEXAPAE’ study. BMJ Publishing Group.
Style de citation Chicago (17e éd.)Lonn, Lars, Hein Vincent Stroomberg, Klaus Brasso, Martin Andreas Roder, Petra Svarc, Ruben Juhl Jensen, Susanne Frevert, Mats Håkan Lindh, et Mikkel Taudorf. Efficacy of Dexamethasone in Reducing the Postembolisation Syndrome in Men Undergoing Prostatic Artery Embolisation for Benign Prostatic Hyperplasia: Protocol for a Single-centre, Randomised, Double-blind, Placebo-controlled Trial—the ‘DEXAPAE’ Study. BMJ Publishing Group, 2021.
Style de citation MLA (8e éd.)Lonn, Lars, et al. Efficacy of Dexamethasone in Reducing the Postembolisation Syndrome in Men Undergoing Prostatic Artery Embolisation for Benign Prostatic Hyperplasia: Protocol for a Single-centre, Randomised, Double-blind, Placebo-controlled Trial—the ‘DEXAPAE’ Study. BMJ Publishing Group, 2021.